These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33581708)

  • 41. Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center.
    Shani H; Goldwaser T; Keating J; Klugman S
    Am J Obstet Gynecol; 2016 Jun; 214(6):729.e1-729.e11. PubMed ID: 26721783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive prenatal testing.
    Lo JO; Cori D F; Norton ME; Caughey AB
    Obstet Gynecol Surv; 2014 Feb; 69(2):89-99. PubMed ID: 25112487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment.
    Caine A; Maltby AE; Parkin CA; Waters JJ; Crolla JA;
    Lancet; 2005 Jul 9-15; 366(9480):123-8. PubMed ID: 16005334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sonographic scoring index for prenatal detection of chromosomal abnormalities.
    Benacerraf BR; Neuberg D; Bromley B; Frigoletto FD
    J Ultrasound Med; 1992 Sep; 11(9):449-58. PubMed ID: 1283415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
    Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
    Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
    Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
    Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Summary of 2185 prenatal invasive procedures in a single center: A retrospective analysis.
    Özcan HÇ; Uğur MG; Sucu S; Mustafa A; Bayramoğlu Tepe N; Balat Ö
    Turk J Obstet Gynecol; 2017 Jun; 14(2):114-120. PubMed ID: 28913147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Counselling implications of chromosomal abnormalities other than trisomy 21 detected through a maternal serum screening programme.
    Sheridan E; Williams J; Caine A; Morgan R; Mason G; Mueller RF
    Br J Obstet Gynaecol; 1997 Jan; 104(1):42-5. PubMed ID: 8988695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal diagnosis of trisomy 21: registration results from a single genetic center.
    Witters I; Fryns JP
    Genet Couns; 2008; 19(2):157-63. PubMed ID: 18618989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A retrospective exploratory study of fetal genetic invasive procedures at a University Hospital.
    Andrew C; Koshy T; Gopal S; Paul SFD
    J Obstet Gynaecol; 2018 Oct; 38(7):906-910. PubMed ID: 29553859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
    Hume H; Chasen ST
    Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Analysis of prenatal follow-up strategies for trisomy 21 affected pregnancies in France].
    Dupont JM; Simon-Bouy B; Zebina A; Pessione F; Royère D; Doco-Fenzy M;
    Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):152-157. PubMed ID: 28258854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The need to reevaluate trisomy screening for advanced maternal age in prenatal diagnosis.
    Clark BA; Kennedy K; Olson S
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):812-6. PubMed ID: 8456886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities.
    Lee JY; Kwon JY; Na S; Choe SA; Seol HJ; Kim M; Kim MA; Park CW; Kim K; Ryu HM; Hwang HS; Shim JY
    J Korean Med Sci; 2021 Jan; 36(4):e26. PubMed ID: 33496085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.
    Rhoads GG; Jackson LG; Schlesselman SE; de la Cruz FF; Desnick RJ; Golbus MS; Ledbetter DH; Lubs HA; Mahoney MJ; Pergament E
    N Engl J Med; 1989 Mar; 320(10):609-17. PubMed ID: 2645520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.